Shamaym Blog

Real-Time Collaboration: The Missing Link to Reducing Delays in Clinical Trials


Bringing groundbreaking new therapies from idea to drugstore is no easy feat, and it is not cheap, either. A 2016 study published in the journal Clinical Trials found that the average cost of a Phase 3 trial ranged from US $11.5 million to US $52.9 million. 

The opportunity cost of delay in clinical trials can be tenfold higher. Praxis estimates that delays can cost pharmaceutical companies a staggering $600,000 to $8 million per day in lost revenues

With 80% of clinical trials running late at least one month, trial sponsors face a great deal of pressure to step up their performance.

Reducing Delays with Real-Time Collaborative Learning

To overcome delays, people involved in the clinical trial must work together effectively. But given the many players in a clinical development process—employees of the trial sponsor, site staff, and the CRO, to name just some—working together smoothly is not so simple. And suboptimal collaboration can lead to all sorts of issues.

Clinical development teams already use dozens of collaboration tools. But there is more to effective collaboration than task management, communication, and coordination. What complex, global teams need is a collaboration solution that leads to improved results by not just helping teams work together, but rather helping them learn and get better together. For a collaboration solution to reduce trial delays and therefore impact the trial’s cost, it should:

  1. Help teams learn and improve. Collaborating on process and tracking progress is one thing. Teams learn important lessons along the way, and they should have a dedicated space to record their learning, as well as a way to retrieve that learning easily later on.
  2. Allow teams to share learning instantly across sites and departments. It is hard to know when the learning of one team could be highly applicable and relevant to another. What if a system could help with that?


Collaborative Real-Time Learning provides the framework and the tools to meet these needs. It helps clinical development teams improve processes with continuous learning. Teams can capture their most valuable lessons learned and associate them with a particular study phase, site, team, or task in a dedicated checklist. 

Real-time collaboration can transform teams. Download the eBook to learn more.

The Power of the Always-Learning Team

Those lessons can be shared across sites, so teams across the globe who might face similar challenges can instantly access their peers’ experiences and get insights into how to do better. And learning that is relevant across types of teams, or even across studies, can be easily surfaced as a reminder when it’s needed. Organizational knowledge and memory is not only retained, it’s put to use.

In this way, clinical development teams can quickly address issues that would cause delays, meet milestones more effectively, and lead to serious dollars saved, just as Dexcel Pharma’s R&D group did using Shamaym’s Collaborative Real-Time Learning Platform.

Clinical development teams need a tool to consolidate their progress as well as the lessons they learn along the way—to prevent mistakes from recurring and ensure the smoothest, and fastest, progression to market. To learn more about Shamaym’s Collaborative Real-Time Learning solution for clinical development teams, click here.